In Brief This Week: Quest Diagnostics, Solstas Lab, Summit Health; Venaxis; MolecularHealth; ValueOptions, Genomind | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics this week said that it completed its acquisition of full-service commercial laboratory firm Solstas Lab Partners Group and its subsidiaries for $570 million. In connection with the deal, Quest raised its guidance for full-year 2014. Revenues are now expected to grow between 2 percent and 4 percent, compared to full-year 2013. It previously said 2014 revenue was anticipated to be flat to down 2 percent year over year, excluding the Solstas purchase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.